Kalbe Farma Owners | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Kalbe Farma

Kalbe Farma | Ownership

Companies that own Kalbe Farma

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

First State Investment Management (UK) Ltd.

1,079,588,215

2.29%

247,312,288

0.45%

01/31/2018

The Vanguard Group, Inc.

627,962,202

1.34%

-3,591,200

07/31/2018

BlackRock Fund Advisors

622,999,500

1.33%

-1,075,500

09/06/2018

RBC Global Asset Management (UK) Ltd.

463,346,500

0.99%

46,585,200

0.21%

07/31/2018

PT Schroder Investment Management Indonesia

434,390,300

0.93%

72,651,300

2.06%

12/31/2017

Massachusetts Financial Services Co.

302,454,700

0.65%

0.01%

07/31/2018

JPMorgan Asset Management (Singapore) Ltd.

218,385,900

0.47%

33,186,000

0.61%

06/30/2018

Mirae Asset Global Investments (Hong Kong) Ltd.

181,294,207

0.39%

-31,555,900

0.83%

01/31/2018

BlackRock Advisors (UK) Ltd.

153,973,359

0.33%

0.01%

09/06/2018

Fidelity Management & Research Co.

139,684,175

0.3%

-55,942,812

07/31/2018

About Kalbe Farma

View Profile

Address	Gedung KALBE Jakarta JK 10510 Indonesia
Employees	-
Website	http://www.kalbe.co.id
Updated	07/08/2019
PT Kalbe Farma Tbk engages in the development, production, distribution, and trade of pharmaceutical products. It operates through the following segments: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical segment offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores throughout Indonesia.